A Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated Myelopathy
Clinical trial NCT01561755 · TERMINATED
Trial details
- NCT number
- NCT01561755
- Sponsor
- David M. Simpson
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2016-09-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.